Navigation Links
The Revelation of Man: A New Novel That Explains The Enduring Survival and Existence of Homosexuals If They Don't Naturally Reproduce
Date:6/14/2011

WASHINGTON, June 14, 2011 /PRNewswire/ -- A fundamental question regarding man's existence has been left unanswered by science and religion for over two thousand years. As homosexuals don't naturally reproduce, their gene pool is not further advanced.  So, how do we explain their enduring survival and existence?  What if their existence served a necessary or divine purpose?  

If we're to believe Darwin's laws of evolution, the mere presence of homosexuals is an impossible outcome. On the other hand, organized religion provides no explanation only to declare homosexuality an abomination.  But what if the earth's population began to decline at an increasing rate?  What if straight men suddenly but steadily began declaring themselves gay?  What if a young government researcher discovered genetic evidence to support this phenomenon?  What if an evangelical preacher stumbled upon this same evidence and used it to proclaim Revelation?

The answers to the above questions can be found in The Revelation of Man.  This riveting novel describes the journey of two desperate men as they seek to unravel the interconnectivity of sexual orientation, genetics and Revelation.  Though they live and work worlds apart, their converging lives allow them to reveal answers that lay beyond anyone's imagination.

The Revelation of Man can be purchased from most E-Book sellers including Apple, Amazon, Barnes & Noble and Smashwords.  


'/>"/>
SOURCE David Schweon
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
2. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
3. Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study with Cimzia® (certolizumab pegol)
4. InVivo Therapeutics and The Miami Project to Cure Paralysis Form Strategic Research Collaboration to Develop Novel Treatments for Spinal Cord Injuries
5. Frost & Sullivan Award Acknowledges Noveldas Cutting-Edge Product Innovation
6. ImaginAb, Inc. Concludes Licensing Agreement With UCLA for Novel Radiochemistry Technology
7. NRL scientists demonstrate novel ionic liquid batteries
8. Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics
9. S*BIO Initiates Phase 2 Clinical Trial of its Novel JAK2 Inhibitor SB1518 in North America for Advanced Lymphoid Malignancies
10. Tolerx Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses
11. Novel nanowires boost fuel cell efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 /PRNewswire/ ... (OGT), das Unternehmen für Molekulargenetik, erweitert seine Palette ... SureSeq myPanel™ NGS Custom FH Panels, das ein ... Hypercholesterinämie (FH) ermöglicht. Das Panel bietet eine Erkennung ... Number Variations (CNV) mit einem einzigen kleinen Panel ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox ... response to client demand KbioBox developed a sophisticated “3 click” gene dditing off ... accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by the ...
(Date:12/8/2016)... ... ... This CAST literature review and report looks at problems caused by the current ... in countries that are major global commodity exporters and importers, which show that asynchrony ... level presence (LLP) puts large volumes of trade worth billions of dollars at risk. ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):